Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Hartmann

Showing results (151-160 of 251) with videos related to

Pageof 26
Sort By:
Bone Marrow Transplantation|August 16, 2002
Less frequent catheter dressing changes decrease local cutaneous toxicity of high-dose chemotherapy in children, without increasing the rate of catheter-related infections: results of a randomised trialE Benhamou, E Fessard, C Com-Nougué, et al.
Archives Francaises De Pediatrie|April 1, 1984
[2nd malignant tumors in children. Study of 38 cases]O Oberlin, A Bernard, F Flamant, et al.
British Journal of Cancer|February 5, 2004
Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 casesV Minard-Colin, C Kalifa, J-M Guinebretiere, et al.
Bone Marrow Transplantation|May 7, 1999
Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institutionO Hartmann, D Valteau-Couanet, G Vassal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantationG Vassal, S Koscielny, D Challine, et al.
British Journal of Cancer|March 10, 1999
Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrationsI Boland, G Vassal, J Morizet, et al.
Progress in Clinical and Biological Research|January 1, 1994
Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysisJ Bénard, J Bourhis, F de Vathaire, et al.
Progress in Clinical and Biological Research|January 1, 1991
Expression of MDR1 and GST pi genes in 35 advanced neuroblastomasJ Bourhis, O Hartmann, F DeVathaire, et al.
Progress in Clinical and Biological Research|January 1, 1988
The therapeutic use of I-131 meta-iodobenzylguanidine (mIBG) in neuroblastoma: a phase II study in 12 patientsO Hartmann, J D Lumbroso, M Lemerle, et al.
Medical and Pediatric Oncology|January 1, 1991
Nonmetastatic thoracic neuroblastomas: a review of 40 casesH Rubie, O Hartmann, A Giron, et al.
Pageof 26

Showing results (151-160 of 251) with videos related to

Sort By:
Pageof 26
Bone Marrow Transplantation|August 16, 2002
Less frequent catheter dressing changes decrease local cutaneous toxicity of high-dose chemotherapy in children, without increasing the rate of catheter-related infections: results of a randomised trialE Benhamou, E Fessard, C Com-Nougué, et al.
Archives Francaises De Pediatrie|April 1, 1984
[2nd malignant tumors in children. Study of 38 cases]O Oberlin, A Bernard, F Flamant, et al.
British Journal of Cancer|February 5, 2004
Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 casesV Minard-Colin, C Kalifa, J-M Guinebretiere, et al.
Bone Marrow Transplantation|May 7, 1999
Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institutionO Hartmann, D Valteau-Couanet, G Vassal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantationG Vassal, S Koscielny, D Challine, et al.
British Journal of Cancer|March 10, 1999
Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrationsI Boland, G Vassal, J Morizet, et al.
Progress in Clinical and Biological Research|January 1, 1994
Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysisJ Bénard, J Bourhis, F de Vathaire, et al.
Progress in Clinical and Biological Research|January 1, 1991
Expression of MDR1 and GST pi genes in 35 advanced neuroblastomasJ Bourhis, O Hartmann, F DeVathaire, et al.
Progress in Clinical and Biological Research|January 1, 1988
The therapeutic use of I-131 meta-iodobenzylguanidine (mIBG) in neuroblastoma: a phase II study in 12 patientsO Hartmann, J D Lumbroso, M Lemerle, et al.
Medical and Pediatric Oncology|January 1, 1991
Nonmetastatic thoracic neuroblastomas: a review of 40 casesH Rubie, O Hartmann, A Giron, et al.
Pageof 26